Eurofins Technologies Launches an Enhanced Variant of Concern-Discriminating PCR Test Including the South African Variant (B.1.351)
Eurofins Technologies announces the launch of its GSD NovaType II, its upgraded RT-PCR kit for the identification of mutations associated with SARS-CoV-2 variants of concern.
- Eurofins Technologies announces the launch of its GSD NovaType II, its upgraded RT-PCR kit for the identification of mutations associated with SARS-CoV-2 variants of concern.
- The GSD NovaType II kit delivers results under two hours.
- It is therefore well suited to timely screening and relieving sequencing capacities for use in epidemiological studies.
- The assay has been validated on the AriaMxTM and AriaDxTM qPCR platforms from Agilent Technologies and will soon be validated on additional thermocyclers.